Effects of L-701,324, a high-affinity antagonist at the N-methyl-D-aspartate (NMDA) receptor glycine site, on the rat electroencephalogram

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 355, Issue 6, 1997, Pages 779-786

  Obrenovitch, Tihomir P ^a   Hardy, Aidan M ^a   Zilkha, Elias ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anaesthesia; DC potential; Electroencephalogram; L 701,324; Microdialysis electrode; N Methyl D aspartate receptor glycine site

Indexed keywords

7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; HALOTHANE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; ELECTROENCEPHALOGRAM; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; RAT;

ANIMALS; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; MALE; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030853696     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005013     Document Type: Article

References (50)

1. Anis NA, Berry SV, Burton NR, Lodge D (1983) The dissociative anesthetics ketamine and phencyclidine selectively reduce excitation of central mammalian neurones by N-methylaspartate. Br J Pharmacol 79:565-575
2. Bliss TVP, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature (Lond) 361:31-39
3. Bristow LJ, Hutson PH, Young L, Saywell KL, Gay JC, Tricklebank MD (1995) Behavioural pharmacology of glycine/ NMDA receptor antagonists. Behav Pharmacol 6:617
4. Bristow LJ, Hutson PH, Kulagowski JJ, Leeson PD, Matheson S, Murray F, Rathbone D, Saywell KL, Thorn L, Watt AP, Tricklebank MD (1996) Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex. J Pharmacol Exp Ther 279:492-501
5. Bronzino JD, Siok CJ, Austin K, Austin-Lafrance RJ, Morgane PJ (1987) Spectral analysis of the electroencephalogram in the developing rat. Dev Brain Res 35:257-267
6. Carla V, Moroni F (1992) General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neurosci Lett 146:21-24
7. Chapman AG, Meldrum BS (1989) Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice. Eur J Pharmacol 166:201-211
8. Daniell LC (1990) The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamines, increase the potency of general anesthetics. Pharmacol Biochem Behav 36:111-115
9. Dickenson AH (1990) A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 11:307-309
10. Fix AS, Long GG, Wozniak DF, Olney JW (1994) Pathomorphologic effects of N-methyl-D-aspartate antagonists in the rat posterior cingulate/retrosplenial cerebral cortex: A review. Drug Dev Res 32:147-152
11. Iijima T, Mies G, Hossmann K-A (1992) Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: Effect on volume of ischemic injury. J Cereb Blood Flow Metab 12:727-733
12. Iversen SD (1995) Interactions between excitatory amino acids and dopamine systems in the forebrain: implications for schizophrenia and Parkinson's disease. Behav Pharmacol 6:478-490
13. Kari PH, Vyas KP (1994) The physiological disposition of L-701,324 I, a selective glycine/N-methyl-D-aspartate receptor antagonist, in the rat, dog and chimpanzee. Pharm Res 11 [Suppl]:S346
14. Kristensen JD, Svensson B, Gordh T Jr (1992) The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 51:249-253
15. Kulagowski JJ, Baker R, Curtis NR, Leeson PD, Mawer IM, Moseley AM, Ridgill MP, Rowley M, Stansfield I, Foster AC, Grimwood S, Hill RG, Kemp JA, Marshall GR, Saywell KL, Tricklebank MD (1994) 3'-(arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: Orally active antagonists of the glycine site on the NMDA receptor. J Med Chem 37:1402-1405
16. Lauritzen M (1994) Pathophysiology of the migraine aura: The spreading depression theory. Brain 117:199-210
17. Lauritzen M, Hansen AJ (1992) The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab 12:223-229
18. Leeson PD, Iversen LL (1994) The glycine site of the NMDA receptor: Structure-activity relationship and therapeutic potential. J Med Chem 37:4053-4067
19. Lipton SA (1993) Molecular mechanisms of trauma-induced neuronal degeneration. Curr Opin Neurol Neurosurg 6:588-596
20. Martin DC, Plagenhoef M, Abraham J, Dennison RL, Aronstam RS (1995) Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol 49:809-817
21. Martin H, Warner DS, Todd MM (1994) Effects of glycine receptor antagonism on spreading depression in the rat. Neurosci Lett 180:285-289
22. Matthews, JNS, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. Br Med J 300:230-235
23. McFarlane C, Warner DS, Dexter F (1995a) Interactions between NMDA and AMPA glutamate receptor antagonists during halothane anesthesia in the rat. Neuropharmacology 34:659-663
24. McFarlane C, Warner DS, Nadler A, Dexter F (1995b) Glycine receptor antagonism. Effects of ACEA-1021 on the minimum alveolar concentration for halothane in rats. Anesthesiology 82:963-968
25. Meldrum BS (1990) Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev 2:27-57
26. Meldrum BS, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11:379-387
27. 2+ transients and glutamate release in isolated cerebral synaptosomes. Anesthesiology 83:593-603
28. Mies G, Kohno K, Hossmann K-A (1994) Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat. J Cereb Blood Flow Metab 14:804-807
29. Obrenovitch TP (1995) The ischaemic penumbra: Twenty years on. Cerebrovasc Brain Metab Rev 7:297-323
30. Obrenovitch TP, Zilkha E (1996) Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex. Br J Pharmacol 117:931-937
31. Obrenovitch TP, Matsumoto T, Symon L (1989) Multiparametric monitoring of the rat cerebral cortex subjected to transient ischemia: A Powerful tool for assessing "anti-ischemic" drugs. J Cereb Blood Flow Metabol 9 [Suppl 1]:S630
32. Obrenovitch TP, Richards DA, Sarna GS, Symon L (1993) Combined intracerebral microdialysis and electrophysiological recording: Methodology and applications. J Neurosci Methods 47:139-145
33. Obrenovitch TP, Urenjak J, Zilkha E (1994) Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo. Br J Pharmacol 113:1295-1302
34. Obrenovitch TP, Hardy AM, Zilkha E (1996) Effects of L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate (NMDA) receptor, on the electroencephalogram and NMDA-evoked responses in the rat striatum. Br J Pharmacol 117 [Suppl]:26P
35. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, London
36. Priestley T, Danks P, Marshall GR, Kemp JA, Kulagowski J, Leeson PD, Hill RG (1994) L-701,324: a high affinity antagonist at the glycine-recognition site of the NMDA receptor. Br J Pharmacol 113 [Suppl]:31P
37. Saywell K, Bristow LJ, Foster AC, Grimwood S, Hill RG, Huston PH, Kulagowski J, Leeson PD, Tricklebank MD (1995) The pharmacological profile of the glycine/NMDA receptor antagonist, L-701,324. Br J Pharmacol 114 [Suppl]:320P
38. Sheardown MJ (1993) The triggering of spreading depression in the chicken retina: a pharmacological study. Brain Res 607:189-194
39. Schlame M, Hemmings HC (1995) Inhibition by volatile anesthetics of endogenous glutamate release from synaptosomes by a presynaptic mechanism. Anesthesiology 82:1406-1416
40. Smith ID, Todd MJ, Beninger RJ (1996) Glutamate receptor agonist injections into the dorsal striatum cause contralateral turning in the rat - Involvement of kainate and AMPA receptors. Eur J Pharmacol 301:7-17
41. +. Proc Natl Acad Sci USA 87:6445-6449
42. Thomson AM (1989) Glycine modulation of the NMDA receptor/channel complex. Trends Neurosci 12:349-353
43. Tortella FC, Hill RG (1996) EEG seizure activity and behavioral neurotoxicity produced by (+)-MK801, but not the glycine site antagonist L-687,414, in the rat. Neuropharmacology 35:441-448
44. Turski L, Turski WA (1993) Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology. Experientia 49:1064-1072
45. Urenjak J, Zilkha E, Gotoh M, Obrenovitch TP (1996) Effect of extracellular acidosis on N-methyl-D-aspartate (NMDA)-evoked responses in vivo. Br J Pharmacol 118 [Suppl]:45P
46. Walz P, Ebert U, Löscher W (1994) Low doses of the glycine/ NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats. Eur J Neurosci 6:1710-1719
47. Warner DS, Martin H, Ludwig P, McAllister A, Keana JFW, Weber E (1995) In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J Cereb Blood Flow Metab 15:188-196
48. Willetts J, Balster RL, Leander JD (1990) The behavioral pharmacology of NMDA receptor antaconists. Trends Pharmacol Sci 11:423-428
49. Woodward RM, Huettner JE, Guastella J, Keana JF, Weber E (1995) In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinadiones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol Pharmacol 47:568-581
50. Yamamura T, Harada K, Okamura A, Kemmotsu O (1990) Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor? Anesthesiology 72:704-710